Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 566

1.

Cancer trends and burden in India - Authors' response.

Mathur P, Mehrotra R, Fitzmaurice C, Dhillon PK, Nandakumar A, Dandona L; India State-Level Disease Burden Initiative Cancer Collaborators.

Lancet Oncol. 2018 Dec;19(12):e664. doi: 10.1016/S1470-2045(18)30857-X. No abstract available.

PMID:
30507424
2.

Safety and cardiovascular efficacy of spironolactone in dialysis-dependent ESRD (SPin-D): a randomized, placebo-controlled, multiple dosage trial.

Charytan DM, Himmelfarb J, Ikizler TA, Raj DS, Hsu JY, Landis JR, Anderson AH, Hung AM, Mehrotra R, Sharma S, Weiner DE, Williams M, DiCarli M, Skali H, Kimmel PL, Kliger AS, Dember LM; Hemodialysis Novel Therapies Consortium.

Kidney Int. 2018 Nov 22. pii: S0085-2538(18)30641-0. doi: 10.1016/j.kint.2018.08.034. [Epub ahead of print]

PMID:
30473139
3.

Genetic landscape of gallbladder cancer: Global overview.

Mehrotra R, Tulsyan S, Hussain S, Mittal B, Singh Saluja S, Singh S, Tanwar P, Khan A, Javle M, Hassan MM, Pant S, De Aretxabala X, Sirohi B, Rajaraman P, Kaur T, Rath GK.

Mutat Res. 2018 Oct - Dec;778:61-71. doi: 10.1016/j.mrrev.2018.08.003. Epub 2018 Aug 23. Review.

PMID:
30454684
4.

Association of Medicaid Expansion With 1-Year Mortality Among Patients With End-Stage Renal Disease.

Swaminathan S, Sommers BD, Thorsness R, Mehrotra R, Lee Y, Trivedi AN.

JAMA. 2018 Dec 4;320(21):2242-2250. doi: 10.1001/jama.2018.16504.

PMID:
30422251
5.

Fostering Innovation in Symptom Management among Hemodialysis Patients: Paths Forward for Insomnia, Muscle Cramps, and Fatigue.

Flythe JE, Hilliard T, Lumby E, Castillo G, Orazi J, Abdel-Rahman EM, Pai AB, Rivara MB, St Peter WL, Weisbord SD, Wilkie CM, Mehrotra R; Kidney Health Initiative Prioritizing Symptoms of ESRD Patients for Developing Therapeutic Interventions Stakeholder Meeting Participants.

Clin J Am Soc Nephrol. 2018 Nov 5. pii: CJN.07670618. doi: 10.2215/CJN.07670618. [Epub ahead of print]

PMID:
30397026
6.

Three-dimensional echocardiographic systolic dyssynchrony index- what is the correct cut-off?

Mehrotra R.

Indian Heart J. 2018 Sep - Oct;70(5):765. doi: 10.1016/j.ihj.2018.08.020. Epub 2018 Sep 5. No abstract available.

7.

Predictors of early mortality and readmissions among dialysis patients undergoing lower extremity amputation.

Hickson LJ, Rule AD, Thorsteinsdottir B, Shields RC, Porter IE, Fleming MD, Ubl DS, Crowson CS, Hanson KT, Elhassan BT, Mehrotra R, Arya S, Albright RC, Williams AW, Habermann EB.

J Vasc Surg. 2018 Nov;68(5):1505-1516. doi: 10.1016/j.jvs.2018.03.408. Epub 2018 Jun 28.

PMID:
30369411
8.

Association between Cyclin D1 G870A (rs9344) polymorphism and cancer risk in Indian population: Meta-analysis and Trial Sequential Analysis.

Thakur N, Kumari S, Mehrotra R.

Biosci Rep. 2018 Oct 25. pii: BSR20180694. doi: 10.1042/BSR20180694. [Epub ahead of print]

PMID:
30361291
9.

Setting Objectives for a Competency-based Undergraduate Obstetrics and Gynecology Curriculum.

Halder A, Joshi A, Mehrotra R, Rathinam B, Shrivastava S.

J Adv Med Educ Prof. 2018 Oct;6(4):147-154.

10.

The changing face of risk factors for non-communicable disease in Myanmar: findings from the 2009 and 2014 WHO STEP Surveys.

Grover S, Sinha DN, Gupta S, Gupta PC, Mehrotra R.

J Public Health (Oxf). 2018 Oct 15. doi: 10.1093/pubmed/fdy176. [Epub ahead of print]

PMID:
30321380
11.

Binding of Platinum Derivative, Oxaliplatin to Deoxyribonucleic Acid: Structural Insight into Antitumor Action.

Ray B, Gupta B, Mehrotra R.

J Biomol Struct Dyn. 2018 Oct 3:1-24. doi: 10.1080/07391102.2018.1531059. [Epub ahead of print]

PMID:
30282523
12.

Dohra- a mixture of potent carcinogens.

Sharma V, Nandan A, Shukla AK, Chandra A, Kaushik R, Sinha DN, Mehrotra R.

Indian J Med Res. 2018 Jul;148(1):116-119. doi: 10.4103/ijmr.IJMR_39_18.

13.

Implementation of Article 20 of the World Health Organization Framework Convention on Tobacco Control.

Sinha DN, Kumar A, Gupta R, Gulati HK, Gupta S, Mehrotra R.

Indian J Med Res. 2018 Jul;148(1):110-115. doi: 10.4103/ijmr.IJMR_288_18.

14.

Setting research priorities in smokeless tobacco control: A retrospective review.

Gulati HK, Kumar A, Dhama AS, Gupta R, Sharma AK, Singh H, Sinha DN, Mehrotra R.

Indian J Med Res. 2018 Jul;148(1):103-109. doi: 10.4103/ijmr.IJMR_80_18.

15.

A review of trade practices of smokeless tobacco products in terms of prohibition on sale, manufacturing & importation in Framework Convention on Tobacco Control ratified Parties.

Saraf DS, Mehrotra R, Chandan K, Sinha DN, Yadav A.

Indian J Med Res. 2018 Jul;148(1):90-97. doi: 10.4103/ijmr.IJMR_2027_17. Review.

16.

A systematic review on association between smokeless tobacco & cardiovascular diseases.

Gupta R, Gupta S, Sharma S, Sinha DN, Mehrotra R.

Indian J Med Res. 2018 Jul;148(1):77-89. doi: 10.4103/ijmr.IJMR_2020_17. Review.

17.

Relationship between type of smokeless tobacco & risk of cancer: A systematic review.

Gupta S, Gupta R, Sinha DN, Mehrotra R.

Indian J Med Res. 2018 Jul;148(1):56-76. doi: 10.4103/ijmr.IJMR_2023_17. Review.

18.

Regulation of toxic contents of smokeless tobacco products.

Kumar A, Bhartiya D, Kaur J, Kumari S, Singh H, Saraf D, Sinha DN, Mehrotra R.

Indian J Med Res. 2018 Jul;148(1):14-24. doi: 10.4103/ijmr.IJMR_2025_17. Review.

19.

Role of World Health Organization Framework Convention on Tobacco Control Global Knowledge Hub on Smokeless Tobacco.

Mehrotra R, Grover S, Chandra A.

Indian J Med Res. 2018 Jul;148(1):7-13. doi: 10.4103/ijmr.IJMR_2036_17. Review.

20.

Global challenges in smokeless tobacco control.

Mehrotra R, Sinha DN.

Indian J Med Res. 2018 Jul;148(1):1-3. doi: 10.4103/ijmr.IJMR_32_18. No abstract available.

Supplemental Content

Loading ...
Support Center